10466-72-5Relevant articles and documents
Synthesis of DNP-modified GM3-based anticancer vaccine and evaluation of its immunological activities for cancer immunotherapy
Lin, Han,Hong, Haofei,Feng, Lipeng,Shi, Jie,Zhou, Zhifang,Wu, Zhimeng
, p. 4041 - 4044 (2021)
Tumor-associated carbohydrate antigens (TACAs) are attractive targets for vaccine development. In this context, we described a strategy combining artificial TACA and glycoengineering for cancer vaccine development. A 2,4-ditrophenyl (DNP)-modified GM3 int
Pharmacokinetic studies with 3H-labelled synthetic antifibrinolytics
Richter,Markwardt,Kloecking
, p. 851 - 853 (2007/10/02)
In rabbits and rats pharmacokinetic studies on the anti-fibrinolytics 4-aminomethylbenzoic acid (PAMBA), trans-4-aminomethylcyclohexane-1-carboxylic acid (AMCA), and epsilon-aminocaproic acid (EACA) were carried out using the tritium labelled compounds. F